Sebestyén, E;
Nagy, Á;
Marosvári, D;
Rajnai, H;
Kajtár, B;
Deák, B;
Matolcsy, A;
... Reiniger, L; + view all
(2022)
Distinct miRNA Expression Signatures of Primary and Secondary Central Nervous System Lymphomas.
The Journal of Molecular Diagnostics
, 24
(3)
pp. 224-240.
10.1016/j.jmoldx.2021.11.005.
Preview |
Text
Sebestyen_et_al_Genome_Med_2021_01_10_SB.pdf - Accepted Version Download (372kB) | Preview |
Abstract
Central nervous system (CNS) lymphoma is a rare and aggressive non-Hodgkin lymphoma that might arise in the CNS (primary CNS lymphoma) or disseminates from a systemic lymphoma to the CNS (secondary CNS lymphoma). Dysregulated expression of miRNAs is associated with various pathologic processes, and miRNA expression patterns may have diagnostic, prognostic, and therapeutic implications. However, miRNA expression is understudied in CNS lymphomas. We performed expression analysis of 798 miRNAs in 73 CNS lymphoma samples using the NanoString platform, followed by an analysis to identify potential diagnostic biomarkers characterizing subgroups and to examine differences based on their primary and secondary nature, molecular subtype, mutational patterns, and survival. We identified 31 differentially expressed miRNAs between primary and secondary groups. In addition, we identified 7 more miRNAs associated with a molecular subtype and 25 associated with mutation status. Using unsupervised clustering methods, we defined a small but distinct primary CNS lymphoma subgroup, with characteristically different expression patterns compared with the rest of the cases. Finally, we identified differentially regulated pathways in the above comparisons and assessed the utility of miRNA expression patterns in predicting survival. Our study identifies a novel CNS lymphoma subgroup defined by distinct miRNAs, proves the importance of specific miRNAs and pathways in their pathogenesis, and provides the basis for future research in defining potential biomarkers.
Archive Staff Only
 |
View Item |
